Renal Dose Adjustment for Pregabalin in a 74-Year-Old with eGFR 50 mL/min
For this patient with an eGFR of approximately 50 mL/min, the pregabalin dose of 75 mg BID (150 mg/day total) should be reduced to 75 mg/day total, administered as either 25-50 mg BID or 75 mg once daily. 1
Dosing Algorithm Based on Renal Function
The FDA label provides explicit guidance for pregabalin dose adjustment based on creatinine clearance (CLcr), which correlates closely with eGFR 1:
For CLcr 30-60 mL/min (which includes your patient with eGFR ~50): The total daily dose should be reduced by 50% compared to normal renal function dosing 1, 2
Specific calculation for this patient:
- Intended dose with normal renal function: 150 mg/day (75 mg BID)
- Adjusted dose for CLcr 50 mL/min: 75 mg/day total
- This can be given as 25-50 mg BID or 75 mg once daily 1
Rationale for Dose Reduction
Pregabalin is eliminated primarily by renal excretion (>90% unchanged in urine), making renal function the single most clinically significant factor affecting drug clearance 1, 3, 4. Population pharmacokinetic studies demonstrate that pregabalin clearance is directly proportional to creatinine clearance, with a 56-58% correlation 3, 2.
In patients with CLcr 30-60 mL/min, pregabalin AUC (area under the curve) approximately doubles compared to those with normal renal function, necessitating the 50% dose reduction to maintain equivalent systemic exposure 2.
Special Considerations in Older Adults
This 74-year-old patient requires additional caution beyond standard renal dosing 5:
Start with the lowest dose in the adjusted range (25 mg BID or 50 mg once daily initially) because older adults are particularly susceptible to CNS adverse effects including somnolence, dizziness, mental clouding, balance disorder, tremor, and confusional state 5, 1
Titrate slowly with incremental increases at intervals long enough to monitor for adverse effects, as the effective dose in older adults is often lower than in younger patients 5
The geriatric guideline specifically recommends pregabalin starting doses of 25-50 mg/day for patients with moderate or greater renal impairment 5
Clinical Pitfalls to Avoid
Critical warning: Do not rely on serum creatinine alone in older adults, as it may appear falsely normal despite significant renal impairment due to decreased muscle mass 6. This patient's creatinine of 1.4 mg/dL with eGFR 50 mL/min exemplifies this phenomenon—the creatinine seems only mildly elevated, but renal function is moderately impaired.
CNS depression risk: Recent case reports document severe synergistic CNS depression with pregabalin in patients with even mild renal impairment (eGFR 77 mL/min), emphasizing the importance of conservative dosing in this population 7.
Monitoring and Titration
- Begin with 25-50 mg/day and increase gradually based on efficacy and tolerability 5
- Maximum total daily dose for this patient should not exceed 75-100 mg/day given the CLcr ~50 mL/min 1
- Monitor closely for somnolence, dizziness, confusion, and falls—the most problematic adverse effects in older adults 5, 1